Paper 1 Target Journals
Note: Add an entry below and a line supporting your choice, or second someone else's choice.
Varun:
NEJM - High impact for clinical audience. Published multiple CDC-authored papers on EVALI.
David:
I second NEJM. It may also be worth considering pulmonary/respiratory medicine journals such as The Lancet Respiratory Medicine and American Journal of Respiratory and Critical Care Medicine.
Varun:
NEJM - High impact for clinical audience. Published multiple CDC-authored papers on EVALI.
David:
I second NEJM. It may also be worth considering pulmonary/respiratory medicine journals such as The Lancet Respiratory Medicine and American Journal of Respiratory and Critical Care Medicine.
I second NEJM. It may also be worth considering pulmonary/respiratory medicine journals such as The Lancet Respiratory Medicine and American Journal of Respiratory and Critical Care Medicine.